INSMED INC Operating Leases, Rent Expense
INSMED INC (INSM) reported Operating Leases, Rent Expense of $400.00 thousand for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-10-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-02-25
- INSMED INC operating leases, rent expense for the quarter ending 2019-09-30 was $400.00K, a 0.00% change year-over-year.
- INSMED INC operating leases, rent expense for the quarter ending 2019-06-30 was $800.00K, a 100.00% increase year-over-year.
- INSMED INC operating leases, rent expense for the quarter ending 2019-03-31 was $800.00K, a 100.00% increase year-over-year.
- INSMED INC operating leases, rent expense for the quarter ending 2018-12-31 was $900.00K, a 125.00% increase year-over-year.
- INSMED INC operating leases, rent expense for fiscal 2018 was $2.10M, a 40.00% increase from fiscal 2017.
- INSMED INC operating leases, rent expense for fiscal 2017 was $1.50M, a 25.00% increase from fiscal 2016.
- INSMED INC operating leases, rent expense for fiscal 2016 was $1.20M, a 50.00% increase from fiscal 2015.
- INSMED INC operating leases, rent expense for fiscal 2015 was $800.00K, a 38.46% decline from fiscal 2014.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|
| 2019-09-30 | $400.00K 10-Q · filed 2019-10-30 | $1.20M derived: sum of 2 quarters · filed 2019-10-30 | $2.00M 10-Q · filed 2019-10-30 | $2.90M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $800.00K 10-Q · filed 2019-08-01 | $1.60M 10-Q · filed 2019-08-01 | $2.50M derived: sum of 3 quarters · filed 2021-02-25 | $2.90M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $800.00K 10-Q · filed 2019-05-07 | $1.70M derived: sum of 2 quarters · filed 2021-02-25 | $2.10M derived: sum of 3 quarters · filed 2021-02-25 | $2.50M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.30M derived: sum of 2 quarters · filed 2021-02-25 | $1.70M derived: sum of 3 quarters · filed 2021-02-25 | $2.10M 10-K · filed 2021-02-25 |
| 2018-09-30 | $400.00K 10-Q · filed 2019-10-30 | $800.00K derived: sum of 2 quarters · filed 2019-10-30 | $1.20M 10-Q · filed 2019-10-30 | $1.60M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $400.00K 10-Q · filed 2019-08-01 | $800.00K 10-Q · filed 2019-08-01 | $1.20M derived: sum of 3 quarters · filed 2020-02-25 | $1.60M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $400.00K 10-Q · filed 2019-05-07 | $800.00K derived: sum of 2 quarters · filed 2020-02-25 | $1.20M derived: sum of 3 quarters · filed 2020-02-25 | $1.50M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $800.00K derived: sum of 2 quarters · filed 2020-02-25 | $1.10M derived: sum of 3 quarters · filed 2020-02-25 | $1.50M 10-K · filed 2020-02-25 |
| 2017-09-30 | $400.00K 10-Q · filed 2018-10-30 | $700.00K derived: sum of 2 quarters · filed 2018-10-30 | $1.10M 10-Q · filed 2018-10-30 | $1.40M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | $300.00K 10-Q · filed 2018-08-02 | $700.00K 10-Q · filed 2018-08-02 | $1.00M derived: sum of 3 quarters · filed 2019-02-22 | $1.40M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | $400.00K 10-Q · filed 2018-05-02 | $700.00K derived: sum of 2 quarters · filed 2019-02-22 | $1.10M derived: sum of 3 quarters · filed 2019-02-22 | $1.40M derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $700.00K derived: sum of 2 quarters · filed 2019-02-22 | $1.00M derived: sum of 3 quarters · filed 2019-02-22 | $1.20M 10-K · filed 2019-02-22 |
| 2016-09-30 | $400.00K 10-Q · filed 2017-11-02 | $700.00K derived: sum of 2 quarters · filed 2017-11-02 | $900.00K 10-Q · filed 2017-11-02 | $1.10M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $300.00K 10-Q · filed 2017-08-03 | $500.00K 10-Q · filed 2017-08-03 | $700.00K derived: sum of 3 quarters · filed 2018-02-23 | $900.00K derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $200.00K 10-Q · filed 2017-05-03 | $400.00K derived: sum of 2 quarters · filed 2018-02-23 | $600.00K derived: sum of 3 quarters · filed 2018-02-23 | $800.00K derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $400.00K derived: sum of 2 quarters · filed 2018-02-23 | $600.00K derived: sum of 3 quarters · filed 2018-02-23 | $800.00K 10-K · filed 2018-02-23 |
| 2015-09-30 | $200.00K 10-Q · filed 2016-11-03 | $400.00K derived: sum of 2 quarters · filed 2016-11-03 | $600.00K 10-Q · filed 2016-11-03 | $900.00K derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $200.00K 10-Q · filed 2016-08-04 | $400.00K 10-Q · filed 2016-08-04 | $700.00K derived: sum of 3 quarters · filed 2017-02-23 | $1.10M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $200.00K 10-Q · filed 2016-05-05 | $500.00K derived: sum of 2 quarters · filed 2017-02-23 | $900.00K derived: sum of 3 quarters · filed 2017-02-23 | $1.20M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $700.00K derived: sum of 2 quarters · filed 2017-02-23 | $1.00M derived: sum of 3 quarters · filed 2017-02-23 | $1.30M 10-K · filed 2017-02-23 |
| 2014-09-30 | $400.00K 10-Q · filed 2015-11-06 | $700.00K derived: sum of 2 quarters · filed 2015-11-06 | $1.00M 10-Q · filed 2015-11-06 | $1.20M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $300.00K 10-Q · filed 2015-08-06 | $600.00K 10-Q · filed 2015-08-06 | $800.00K derived: sum of 3 quarters · filed 2016-02-25 | $1.00M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $300.00K 10-Q · filed 2015-05-07 | $500.00K derived: sum of 2 quarters · filed 2016-02-25 | $700.00K derived: sum of 3 quarters · filed 2016-02-25 | $900.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $400.00K derived: sum of 2 quarters · filed 2016-02-25 | $600.00K derived: sum of 3 quarters · filed 2016-02-25 | $1.00M 10-K · filed 2016-02-25 |
| 2013-09-30 | $200.00K 10-Q · filed 2014-11-06 | $400.00K derived: sum of 2 quarters · filed 2014-11-06 | $800.00K 10-Q · filed 2014-11-06 | |
| 2013-06-30 | $200.00K 10-Q · filed 2014-08-06 | $600.00K 10-Q · filed 2014-08-06 | ||
| 2013-03-31 | $200.00K 10-Q · filed 2014-05-08 | |||
| 2012-12-31 | $1.00M 10-K · filed 2015-02-27 | |||
| 2012-09-30 | $200.00K 10-Q · filed 2013-11-05 | $400.00K derived: sum of 2 quarters · filed 2013-11-05 | $600.00K derived: sum of 3 quarters · filed 2013-11-05 | |
| 2012-06-30 | $200.00K 10-Q · filed 2013-08-06 | $400.00K derived: sum of 2 quarters · filed 2013-08-06 | ||
| 2012-03-31 | $200.00K 10-Q · filed 2013-05-07 | |||
| 2011-12-31 | $1.00M 10-K · filed 2014-03-06 | |||
| 2010-12-31 | $500.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |